Malvallin™ Is on Our Radar: Why Orizi’s R&D Team Is Taking a Closer Look at This Structural Skin Active

Written & researched by Creaton Poh, Product Development Writer · Technical input by ORIZI Group R&D Team · Fact-checked by Creaton Poh · Published by ORIZI Group · Last reviewed July 2026

Disclosure: This article is published by ORIZI Group and may refer to our own manufacturing experience, services and capabilities. External factual claims are supported by cited sources.

Croda has since applied a different kind of engineering to its best-known peptide. We look at the encapsulated Matrixyl® Neolide™ active and why we treat it as a process decision in a follow-up article.

Quick Answer

Malvallin is an emerging structural skin active that ORIZI Group’s R&D team is evaluating for future formulations. Its multi-layer mechanism and supplier clinical data suggest potential benefits for skin structure and appearance. ORIZI Group monitors and trials new actives like this so clients can access innovative, evidence-based formulations – this is an evaluation, not a finished-product claim.

Key Takeaways

Malvallin is an emerging structural skin active that the ORIZI Group R&D team is evaluating for future formulations.
Its multi-layer mechanism and the supplier clinical data suggest potential benefits for skin structure and appearance.
ORIZI Group monitors and trials new actives like this so clients can access innovative, evidence-based formulations.

We follow every in-cosmetics Global closely. Not for the spectacle of it — though there is plenty of that — but because every couple of years, something genuinely different shows up. An ingredient that makes you think, that changes how a problem can be solved.

Malvallin™ by Croda Beauty is one of those ingredients. We started looking at it when it appeared at in-cosmetics Global 2026, and it’s been sitting in our evaluation queue ever since. I want to share what we’re seeing and why we think it warrants serious attention from OEM formulators — and from brands who are trying to build meaningful longevity claims.

What Is It, Exactly?

Malvallin™ is a botanical extract derived from the fruit of Malva verticillata — Chinese mallow — developed at Croda’s Sederma research centre in France. The INCI is: Water (and) Pentylene Glycol (and) Decyl Glucoside (and) Malva Verticillata Fruit Extract. It’s preservative-free, 100% naturally derived under ISO 16128, COSMOS natural approved, IECIC-listed, and holds Halal, Vegan, and RSPO MBAL certification.

Croda positions it as a “3D architect” active — and that framing is actually accurate to the mechanism, not just marketing language.

The Three-Layer Mechanism: What Gets Our Attention

Most botanical actives we evaluate work primarily at the epidermis. Some penetrate to the dermis. What makes Malvallin™ unusual — and what put it on our watchlist — is the claim that it operates across all three layers of the skin simultaneously:

At the hypodermis: Stimulates adipocyte differentiation and adiponectin synthesis. That translates to supporting the subcutaneous fat layer — the tissue that gives cheeks their natural volume and fullness. Volume loss there is one of the earliest and most visible signs of structural ageing.
At the dermis: Reinforces extracellular matrix integrity and the dermo-epidermal junction. Practically speaking: collagen and elastin scaffolding support.
At the epidermis: Upregulates antioxidant defences, hydration pathways, and barrier proteins including Cornulin and ceramides.

From a formulation standpoint, an ingredient that genuinely delivers across all three planes — if the clinical evidence holds up at standard use levels — changes the efficiency equation considerably. You’re not layering three separate actives to cover those planes; one well-chosen botanical may address all three.

What Croda’s Clinical Data Shows

In a 28-day study, results reported include: measurable cheek hollow volume reduction (3D scanning), improved skin firmness and extensibility, reduced roughness and redness, increased hydration, and a validated attractiveness signal via eye-tracking (longer gaze duration on the cheekbone area). The eye-tracking methodology is interesting — it moves the efficacy claim away from purely subjective self-assessment toward a behavioural measure, which is stronger evidentially.

We’re not able to verify these results independently until we have the product data sheet and can design our own in-house evaluation at relevant use concentrations. That is the next step for us.

Malvallin product page on Croda Beauty's website — Malvallin™ on Croda Beauty’s official product page — the starting point for our evaluation. *Image: screenshot of crodabeauty.com, captured June 2026. Credit: Croda Beauty.*

What This Could Mean for Our Clients

A few of the brands we work with are developing longevity-positioned facial serums and creams. The shift away from the language of “anti-ageing” toward “skin preservation” and “prejuvenation” is real in their target markets — particularly for brands facing younger consumers (28–40) who want to protect their skin structure before visible ageing begins, not correct it after.

An active that:

Is COSMOS approved (opens doors to certified natural ranges)
Is IECIC-listed (eases China registration)
Works across hypodermis / dermis / epidermis (supports multiple claims)
Is preservative-free (clean formulation compatibility)

…is genuinely interesting from an OEM product development angle. We’re evaluating it with that context in mind.

Where We Are in the Evaluation

We have reached out to Croda for sample material and the full technical data sheet. We haven’t formulated with it yet, and we haven’t verified the use-level or pH range through our own testing. This post reflects where we are right now: we’ve reviewed the publicly available data and we’re interested enough to take it further. We’ll share more once our internal evaluation is underway.

If you’re a brand we work with and you’re interested in exploring Malvallin™ in a formulation concept, reach out to us directly — we’re happy to include it in our next round of actives testing.

Useful Links

This post reflects the Orizi R&D team’s current evaluation of publicly available ingredient information. We are in the process of obtaining samples for internal testing. No finished products, efficacy outcomes, or supplier partnerships with Croda are claimed or implied. Information is accurate as of June 2026.

Related from ORIZI Group: Explore our full OEM manufacturing services and the products we manufacture, or contact our team to start your project.